Maazouz Yassine, Montufar Edgar B, Malbert Julien, Espanol Montserrat, Ginebra Maria-Pau
Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya, BarcelonaTech (UPC), Av. Diagonal 647, 08028 Barcelona, Spain.
Biomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Metallurgical Engineering, Universitat Politècnica de Catalunya, BarcelonaTech (UPC), Av. Diagonal 647, 08028 Barcelona, Spain; Institute for Bioengineering of Catalonia, C. Baldiri Reixach 10, 08028 Barcelona, Spain.
Acta Biomater. 2017 Feb;49:563-574. doi: 10.1016/j.actbio.2016.11.043. Epub 2016 Nov 18.
Although calcium phosphate cements (CPCs) are used for bone regeneration in a wide range of clinical applications, various physicochemical phenomena are known to hinder their potential use in minimally invasive surgery or in highly vascularized surgical sites, mainly because of their lack of injectability or their low washout resistance. The present work shows that the combination of CPCs with an inverse-thermoresponsive hydrogel is a good strategy for finely tuning the cohesive and rheological properties of CPCs to achieve clinical acceptable injectability to prevent phase separation during implantation and cohesion to avoid washout of the paste. The thermoresponsive CPC developed combines alpha-tricalcium phosphate with an aqueous solution of pluronic F127, which exhibits an inverse thermoresponsive behaviour, with a gelling transformation at around body temperature. These novel CPCs exhibited temperature-dependent properties. Addition of the polymer enhanced the injectability of the paste, even at a low liquid-to-powder ratio, and allowed the rheological properties of the cement to be tuned, with the injection force decreasing with the temperature of the paste. Moreover, the cohesion of the paste was also temperature-dependent and increased as the temperature of the host medium increased due to gelling induced in the paste. The thermoresponsive cement exhibited excellent cohesion and clinically acceptable setting times at 37°C, irrespective of the initial temperature of the paste. The addition of pluronic F127 slightly delayed the setting reaction in the early stages but did not hinder the full transformation to calcium-deficient hydroxyapatite. Moreover, the frozen storage of premixed thermoresponsive cement pastes was explored, the main physicochemical properties of the cements being maintained upon thawing, even after 18months of frozen storage. This avoids the need to mix the cement in the operating theatre and allows its use off-the-shelf. The reverse thermoresponsive cements studied herein open up new perspectives in the surgical field, where the sequential gelling/hardening of these novel cements could allow for a better and safer clinical application.
Calcium phosphate cements are attractive bone substitutes due to their similarity to the bone mineral phase. Although they can be injectable, cohesion and stability of the paste are crucial in terms of performance and safety. A common strategy is the combination with hydrogels. However, this often results in a decrease of viscosity with increasing temperature, which can lead to extravasation and particle leakage from the bone defect. The preferred evolution would be the opposite: a low viscosity would enhance mixing and injection, and an instantaneous increase of viscosity after injection would ensure washout resistance to the blood flow. Here we develop for the first time a calcium phosphate cement exhibiting reverse thermoresponsive properties using a poloxamer featuring inverse thermal gelling.
尽管磷酸钙骨水泥(CPCs)在广泛的临床应用中用于骨再生,但已知各种物理化学现象会阻碍其在微创手术或高度血管化手术部位的潜在应用,主要是因为它们缺乏可注射性或抗冲洗性低。目前的研究表明,将CPCs与反相热响应水凝胶相结合是一种很好的策略,可以微调CPCs的内聚性和流变学性质,以实现临床上可接受的可注射性,防止植入过程中的相分离,并具有内聚性以避免糊剂被冲洗掉。所开发的热响应CPC将α-磷酸三钙与具有反相热响应行为的普朗尼克F127水溶液相结合,在体温左右发生凝胶转变。这些新型CPCs表现出温度依赖性特性。聚合物的加入增强了糊剂的可注射性,即使在低液粉比下也是如此,并使骨水泥的流变学性质得以调整,注射力随糊剂温度降低。此外,糊剂的内聚性也与温度有关,并且由于糊剂中诱导的凝胶化,随着宿主介质温度的升高而增加。热响应骨水泥在37°C时表现出优异的内聚性和临床上可接受的凝固时间,与糊剂的初始温度无关。加入普朗尼克F127在早期略微延迟了凝固反应,但并不妨碍完全转变为缺钙羟基磷灰石。此外,还探索了预混合热响应骨水泥糊剂的冷冻储存,即使在冷冻储存18个月后解冻,骨水泥的主要物理化学性质仍得以保持。这避免了在手术室中混合骨水泥的需要,并允许其现成使用。本文研究的反相热响应骨水泥在外科领域开辟了新的前景,这些新型骨水泥的顺序凝胶化/硬化可以实现更好、更安全的临床应用。
磷酸钙骨水泥由于其与骨矿物质相的相似性而成为有吸引力的骨替代物。尽管它们可以是可注射的,但糊剂的内聚性和稳定性在性能和安全性方面至关重要。一种常见的策略是与水凝胶结合。然而,这通常会导致粘度随温度升高而降低,这可能导致从骨缺损处渗出和颗粒泄漏。理想的变化应该相反:低粘度将增强混合和注射,注射后粘度立即增加将确保对血流的抗冲洗性。在这里,我们首次使用具有反相热凝胶化的泊洛沙姆开发了一种具有反相热响应特性的磷酸钙骨水泥。